ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain MetastasesPriya Kumthekar, Nuhad K. Ibrahim, Nehal J. Lakhani et al.|Clinical Cancer Research|2020Cited by 242